International Regulatory Classification of Minimally Manipulated and Borderline Cell and Tissue Products: Implications for Mesenchymal Stromal Cell-Based Interventions.

Bilyalov A, Filatov N, Iashina N, Briko A, Chibizov P, Nadelyaeva I, Tikhomirov A, Petrikina A, Vasilyev V, Deev R, Eremin I, Kotenko K

Open source

DOI: 10.3390/bioengineering13101235
Published: 2026 Oct 21
Container: Bioengineering (Basel, Switzerland)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/bioengineering13101235,
  title = {International Regulatory Classification of Minimally Manipulated and Borderline Cell and Tissue Products: Implications for Mesenchymal Stromal Cell-Based Interventions.},
  author = {Bilyalov A and Filatov N and Iashina N and Briko A and Chibizov P and Nadelyaeva I and Tikhomirov A and Petrikina A and Vasilyev V and Deev R and Eremin I and Kotenko K},
  year = {2026},
  journal = {Bioengineering (Basel, Switzerland)},
  doi = {10.3390/bioengineering13101235},
  url = {https://doi.org/10.3390/bioengineering13101235}
}

RIS

TY  - JOUR
TI  - International Regulatory Classification of Minimally Manipulated and Borderline Cell and Tissue Products: Implications for Mesenchymal Stromal Cell-Based Interventions.
AU  - Bilyalov A
AU  - Filatov N
AU  - Iashina N
AU  - Briko A
AU  - Chibizov P
AU  - Nadelyaeva I
AU  - Tikhomirov A
AU  - Petrikina A
AU  - Vasilyev V
AU  - Deev R
AU  - Eremin I
AU  - Kotenko K
PY  - 2026
JO  - Bioengineering (Basel, Switzerland)
DO  - 10.3390/bioengineering13101235
UR  - https://doi.org/10.3390/bioengineering13101235
ER  -

APA

A, B., N, F., N, I., A, B., P, C., I, N., A, T., A, P., V, V., R, D., I, E., & K, K. (2026). International Regulatory Classification of Minimally Manipulated and Borderline Cell and Tissue Products: Implications for Mesenchymal Stromal Cell-Based Interventions.. Bioengineering (Basel, Switzerland). https://doi.org/10.3390/bioengineering13101235

Source records

pubmed · retrieved 2026-11-10T10:25:52.717Z